Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Diabetes Mellitus, Type 2 1 Cushing Syndrome 1 ACTH Syndrome, Ectopic 1

Interventions

Specimen Handling 195 Magnetic Resonance Spectroscopy 148 Biopsy 117 pembrolizumab 91 Carboplatin 85 Cisplatin 77 Nivolumab 71 Cyclophosphamide 69 Paclitaxel 64 Gemcitabine 52 Radiotherapy 48 Bevacizumab 44 durvalumab 41 Dexamethasone 37 Fluorouracil 35 Doxorubicin 35 venetoclax 34 Pemetrexed 33 Capecitabine 33 olaparib 32 Rituximab 31 Oxaliplatin 31 Injections 31 atezolizumab 30 Etoposide 29 fludarabine 28 Radiation 28 Prednisone 28 Lenalidomide 27 Docetaxel 27

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × ASP3662 × 30 days × Clear all

NCT07296484 2026-05-12

CAPTAIN-T2D

Sparrow Pharmaceuticals

Phase 2 Recruiting

ACTH Syndrome, Ectopic, Cushing Syndrome, Diabetes Mellitus, Type 2

Data powered by HemOnc (CC BY 4.0) Colophon ⚡